Status:
ACTIVE_NOT_RECRUITING
CLDN18.2 Targeting PET Imaging in Patients With Gastrointestinal Tumors
Lead Sponsor:
Peking University Cancer Hospital & Institute
Conditions:
Gastrointestinal Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The objective of the study is to constrcut a noninvasive approach 124I-18B10(10L) PET/CT to detect the CLDN18.2 expression of tumor lesions in patients with gastrointestinal tumors and to identify pat...
Eligibility Criteria
Inclusion
- 1\. Aged \>18 years old; ECOG 0 or 1;
- 2\. Patients with Gastrointestinal tumors;
- 3\. Has at least one measurable target lesion according to Response Evaluation Criteria in Solid Tumors (RECIST V1.1);
- 4\. life expectancy \>=12 weeks.
Exclusion
- 1\. Significant hepatic or renal dysfunction;
- 2\. Is pregnant or ready to pregnant;
- 3\. Cannot keep their states for half an hour;
- 4\. Refusal to join the clinical study;
- 5\. Suffering from claustrophobia or other mental diseases;
- 6\. Any other situation that researchers think it is not suitable to participate in the experiment.
Key Trial Info
Start Date :
May 13 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2024
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT04883970
Start Date
May 13 2021
End Date
May 1 2024
Last Update
January 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
HUA ZHU
Beijing, China